C
Calithera Biosciences Inc
OTC:CALA
Calithera Biosciences Inc
OTC:CALA
Price:
0.0002
USD
Market Closed
Market Cap:
$974
Balance Sheet
Balance Sheet Decomposition
Calithera Biosciences Inc
Calithera Biosciences Inc
Balance Sheet Decomposition is not available for
Calithera Biosciences Inc
Calithera Biosciences Inc
Balance Sheet
Calithera Biosciences Inc
Calithera Biosciences Inc
Currency: USD
| Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
34
|
102
|
6
|
11
|
49
|
51
|
60
|
107
|
60
|
26
|
|
| Cash Equivalents |
34
|
102
|
6
|
11
|
49
|
51
|
60
|
107
|
60
|
26
|
|
| Short-Term Investments |
0
|
0
|
64
|
41
|
115
|
85
|
97
|
8
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
1
|
2
|
1
|
2
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
1
|
2
|
1
|
2
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
2
|
3
|
2
|
3
|
2
|
2
|
2
|
2
|
1
|
|
| Total Current Assets |
34
|
104
|
73
|
54
|
168
|
140
|
160
|
119
|
62
|
27
|
|
| PP&E Net |
1
|
1
|
1
|
1
|
2
|
2
|
8
|
6
|
3
|
2
|
|
| PP&E Gross |
1
|
1
|
0
|
1
|
2
|
2
|
8
|
6
|
3
|
2
|
|
| Accumulated Depreciation |
1
|
1
|
0
|
2
|
2
|
3
|
3
|
3
|
3
|
4
|
|
| Long-Term Investments |
0
|
0
|
2
|
0
|
22
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
0
|
|
| Total Assets |
35
N/A
|
105
+201%
|
76
-28%
|
55
-28%
|
193
+251%
|
143
-26%
|
169
+18%
|
126
-26%
|
65
-48%
|
29
-56%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
0
|
1
|
1
|
0
|
1
|
1
|
2
|
2
|
4
|
1
|
|
| Accrued Liabilities |
1
|
3
|
3
|
4
|
9
|
14
|
18
|
16
|
10
|
7
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
29
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
1
|
4
|
4
|
5
|
39
|
15
|
20
|
18
|
14
|
7
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
3
|
1
|
7
|
5
|
2
|
1
|
|
| Total Liabilities |
1
N/A
|
4
+214%
|
4
-9%
|
5
+23%
|
42
+759%
|
16
-62%
|
26
+64%
|
23
-12%
|
16
-32%
|
8
-47%
|
|
| Equity | |||||||||||
| Common Stock |
54
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
41
|
22
|
|
| Retained Earnings |
30
|
52
|
85
|
123
|
150
|
196
|
286
|
376
|
491
|
513
|
|
| Additional Paid In Capital |
9
|
152
|
156
|
172
|
301
|
323
|
429
|
479
|
500
|
511
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
34
N/A
|
100
+200%
|
72
-28%
|
50
-31%
|
150
+201%
|
127
-16%
|
142
+12%
|
102
-28%
|
49
-52%
|
20
-58%
|
|
| Total Liabilities & Equity |
35
N/A
|
105
+201%
|
76
-28%
|
55
-28%
|
193
+251%
|
143
-26%
|
169
+18%
|
126
-26%
|
65
-48%
|
29
-56%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
1
|
1
|
1
|
1
|
2
|
2
|
3
|
4
|
4
|
5
|
|
| Preferred Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
Switch to:
Switch to:
See Also
Discover More
